TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'

Go back to TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'
PACIRA (NASDAQ: PCRX) Delayed: 23.83 -0.53 (2.18%)
Previous Close $24.36    52 Week High $80.25 
Open $24.11    52 Week Low $30.25 
Day High $24.41    P/E N/A 
Day Low $23.72    EPS $-2.08 
Volume 402,799